Adrenal Tumors - Pathogenesis and Therapy

May 1, 2026 updated by: Martin Fassnacht, University of Wuerzburg

Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen

The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Martin Fassnacht, MD
Phone Number: 49-931-201-36507
Email: fassnacht_m@medizin.uni-wuerzburg.de

Study Locations

Germany
- - Würzburg, Germany, 97080
    - Recruiting
    - University of Wuerzburg
    - Contact:
      
      Stefanie Hahner, MD
      
      Email: hahner_s@medizin.uni-wuerzburg.de
    - Contact:
      
      Martin Fassnacht, MD
      
      Email: fassnacht_m@medizin.uni-wuerzburg.de
    - Principal Investigator:
      
      Martin Fassnacht, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 100 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Sampling Method

Non-Probability Sample

Study Population

Patients with adrenal tumors

Description

Inclusion Criteria:

adrenal tumor detected by imaging

Exclusion Criteria:

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Number of groups / cohorts

Cohorts and Interventions

Group / Cohort
Tumor Tumor material and corresponding biosamples from patients with adrenal tumors
control group Biomaterial from patients without adrenal tumor

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Wuerzburg

Collaborators

German Federal Ministry of Education and Research

Deutsche Krebshilfe e.V., Bonn (Germany)

Investigators

Principal Investigator: Martin Fassnacht, MD, U of Wuerzburg

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2002

Primary Completion (Estimated)

December 1, 2030

Study Completion (Estimated)

December 1, 2032

Study Registration Dates

First Submitted

April 28, 2008

First Submitted That Met QC Criteria

April 29, 2008

First Posted (Estimated)

April 30, 2008

Study Record Updates

Last Update Posted (Actual)

May 7, 2026

Last Update Submitted That Met QC Criteria

May 1, 2026

Last Verified